Fengxia Su

413 total citations
7 papers, 210 citations indexed

About

Fengxia Su is a scholar working on Molecular Biology, Pediatrics, Perinatology and Child Health and Obstetrics and Gynecology. According to data from OpenAlex, Fengxia Su has authored 7 papers receiving a total of 210 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 3 papers in Pediatrics, Perinatology and Child Health and 2 papers in Obstetrics and Gynecology. Recurrent topics in Fengxia Su's work include Epigenetics and DNA Methylation (3 papers), Pregnancy and preeclampsia studies (2 papers) and Extracellular vesicles in disease (2 papers). Fengxia Su is often cited by papers focused on Epigenetics and DNA Methylation (3 papers), Pregnancy and preeclampsia studies (2 papers) and Extracellular vesicles in disease (2 papers). Fengxia Su collaborates with scholars based in China, United Kingdom and Hong Kong. Fengxia Su's co-authors include Dan Huang, Litao Wang, Yu‐Wen Su, Qianjin Lu, Ming Zhao, Peng Zhang, Gongping Liang, Guangliang Yin, Limei Wang and Zhengping Li and has published in prestigious journals such as Chemical Science, Clinica Chimica Acta and BJOG An International Journal of Obstetrics & Gynaecology.

In The Last Decade

Fengxia Su

7 papers receiving 208 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Fengxia Su China 6 107 98 33 26 25 7 210
Julie Alejo United States 5 51 0.5× 66 0.7× 12 0.4× 30 1.2× 7 0.3× 5 188
Hisham Abou-Taleb Egypt 8 84 0.8× 29 0.3× 95 2.9× 15 0.6× 40 1.6× 22 317
Chenglu Qin China 10 54 0.5× 155 1.6× 36 1.1× 12 0.5× 5 0.2× 17 281
Farid Zreik Israel 3 105 1.0× 83 0.8× 8 0.2× 12 0.5× 5 0.2× 4 217
Ursula Schulte‐Wrede Germany 6 77 0.7× 210 2.1× 32 1.0× 3 0.1× 10 0.4× 7 308
Cherry Yin‐Yi Chang Taiwan 10 69 0.6× 86 0.9× 91 2.8× 2 0.1× 10 0.4× 36 287
Jiang‐Feng Ye China 10 123 1.1× 220 2.2× 152 4.6× 4 0.2× 37 1.5× 16 395
Atsuya Fujito Japan 8 98 0.9× 24 0.2× 118 3.6× 6 0.2× 27 1.1× 12 391
Eiji Nishio Japan 10 79 0.7× 39 0.4× 45 1.4× 3 0.1× 10 0.4× 29 300
Zengfang Wang China 8 230 2.1× 79 0.8× 115 3.5× 4 0.2× 19 0.8× 10 345

Countries citing papers authored by Fengxia Su

Since Specialization
Citations

This map shows the geographic impact of Fengxia Su's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fengxia Su with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fengxia Su more than expected).

Fields of papers citing papers by Fengxia Su

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fengxia Su. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fengxia Su. The network helps show where Fengxia Su may publish in the future.

Co-authorship network of co-authors of Fengxia Su

This figure shows the co-authorship network connecting the top 25 collaborators of Fengxia Su. A scholar is included among the top collaborators of Fengxia Su based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fengxia Su. Fengxia Su is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Li, Shaogang, Fengxia Su, Yan Zhang, et al.. (2024). Comprehensive evaluation of the impact of whole-genome bisulfite sequencing (WGBS) on the fragmentomic characteristics of plasma cell-free DNA. Clinica Chimica Acta. 566. 120033–120033. 1 indexed citations
2.
Hou, Guixue, Ya Gao, Liona C. Poon, et al.. (2022). Maternal plasma diacylglycerols and triacylglycerols in the prediction of gestational diabetes mellitus. BJOG An International Journal of Obstetrics & Gynaecology. 130(3). 247–256. 15 indexed citations
3.
Chen, Min, Fengxia Su, Jiayan Wang, et al.. (2021). Temporal persistence of residual fetal cell‐free DNA from a deceased cotwin after selective fetal reduction in dichorionic diamniotic twin pregnancies. Prenatal Diagnosis. 41(12). 1602–1610. 6 indexed citations
4.
Zhao, Qianqian, Zhen Ma, Wenjing Wang, et al.. (2020). Lipidomic Biomarkers of Extracellular Vesicles for the Prediction of Preterm Birth in the Early Second Trimester. Journal of Proteome Research. 19(10). 4104–4113. 20 indexed citations
5.
Zhang, Haiping, Peng Zeng, Fengxia Su, et al.. (2019). Detection of fetal trisomy and single gene disease by massively parallel sequencing of extracellular vesicle DNA in maternal plasma: a proof-of-concept validation. BMC Medical Genomics. 12(1). 151–151. 20 indexed citations
6.
Su, Fengxia, Limei Wang, Yueying Sun, et al.. (2014). Highly sensitive and multiplexed analysis of CpG methylation at single-base resolution with ligation-based exponential amplification. Chemical Science. 6(3). 1866–1872. 27 indexed citations
7.
Zhang, Peng, Ming Zhao, Gongping Liang, et al.. (2013). Whole-genome DNA methylation in skin lesions from patients with psoriasis vulgaris. Journal of Autoimmunity. 41. 17–24. 121 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026